PROTAC B-Raf degrader 1 is primarily used in targeted protein degradation research, specifically focusing on the B-Raf protein, which plays a critical role in cell signaling pathways. Its application is significant in studying cancer biology, particularly in cancers driven by B-Raf mutations, such as melanoma. By selectively degrading B-Raf, it helps researchers understand the protein's function and its role in tumor growth. This compound is also utilized in developing potential therapeutic strategies for B-Raf-dependent cancers, offering a novel approach compared to traditional inhibitors. Additionally, it serves as a tool in exploring the broader implications of PROTAC technology in drug discovery and targeted therapy.